Advanced eTAM-seq enables high-fidelity, low-input N 6 -methyladenosine profiling in human cells and embryonic mouse tissues
Authors:
Preprint
Abstract
Functional dissection of N6-methyladenosine (m 6 A), the most abundant internal messenger RNA modification in mammals, demands quantitative, scalable detection technology. We previously reported eTAM-seq, which supports transcriptome-wide quantification of m 6 A by enzyme-assisted adenosine deamination. While effective, TadA8.20—the enzyme used in our first-generation technology—is sensitive not only to m 6 A but also to RNA structure, making accurate detection dependent on the inclusion of control transcriptomes. Here, we introduce eTAM-seq-v2, in which we replace TadA8.20 with TadA8r, a further evolved adenosine deaminase with superior catalytic efficiency. eTAM-seq-v2 supports control-free m 6 A calling with high fidelity. Because enzyme treatment preserves RNA integrity, eTAM-seq surveys >51% of A sites in all expressed genes with moderate sequencing depth (60 million uniquely mapped reads) and delivers robust performance with as little as 10 ng of total RNA (∼500 cells). With eTAM-seq-v2, we delineate the m 6 A landscape across six human cell lines and seven embryonic mouse tissues. While uncovering broadly conserved m 6 A patterns, we reveal that most neighboring m 6 A sites are independently deposited at the single-molecule level. Moving forward, we envision that eTAM-seq-v2 will enable researchers to survey m 6 A in diverse biological contexts and uncover new insights into its regulatory roles.Keywords
Funding Information
- Searle Scholars Program
- the Cancer Research Foundation Young Investigator Program, the American Cancer Society
- David and Lucile Packard Foundation
- The Sloan Foundation
- Howard Hughes Medical Institute
This publication has 40 references indexed in Scilit:
- tRNA modifications tune m6A-dependent mRNA decayCell, 2025
- m6A sites in the coding region trigger translation-dependent mRNA decayMolecular Cell, 2024
- Quantitative mapping of the mammalian epitranscriptomeCurrent Opinion in Genetics & Development, 2024
- N6‐Methyladenosine in Mammalian Messenger RNA: Function, Location, and QuantitationIsrael Journal of Chemistry, 2024
- RNA modifications in hematological malignanciesInternational Journal of Hematology, 2023
- Exclusion of m6A from splice-site proximal regions by the exon junction complex dictates m6A topologies and mRNA stabilityMolecular Cell, 2023
- Landscape and Regulation of m6A and m6Am Methylome across Human and Mouse TissuesMolecular Cell, 2020
- Epitranscriptomics: regulation of mRNA metabolism through modificationsCurrent Opinion in Chemical Biology, 2017
- Comprehensive Analysis of mRNA Methylation Reveals Enrichment in 3′ UTRs and near Stop CodonsCell, 2012
- Nucleotide sequences at the N6-methyladenosine sites of HeLa cell messenger ribonucleic acidBiochemistry, 1977